Nab-Paclitaxel for Relapsed AIDS-Related Kaposi Sarcoma -A Case Report.
Infect Drug Resist
; 17: 1431-1437, 2024.
Article
em En
| MEDLINE
| ID: mdl-38623529
ABSTRACT
Introduction:
Kaposi sarcoma (KS) incidence has decreased since the initiation of combination antiretroviral therapy (cART), but it remains the most common cancer in people with HIV/AIDS (PWHA). PWHA with advanced immunosuppression who initiate antiretroviral therapy are susceptible to the occurrence of an immune reconstitution inflammatory syndrome (IRIS). Case Presentation This report covers the case of a 25-year-old male with AIDS-related KS who relapsed after Liposomal Doxorubicin, but recovered well after administration of nab-paclitaxel (Nab-PTX).Conclusion:
This is a rare case in choosing Nab-PTX to treat relapsed AIDS-KS and get good feedback. We report the case to provide a possible solution to treat AIDS-KS.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Infect Drug Resist
Ano de publicação:
2024
Tipo de documento:
Article